← Back to Search

Behavioral Intervention

E-cigarette ad exposure for Positive Perceptions About Cigarette Smoking

N/A
Waitlist Available
Led By Diane Gilbert-Diamond, ScD
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
-
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 30 minutes post intervention
Awards & highlights

Summary

This research aims to investigate how exposure to advertising for Electronic Nicotine Delivery Systems (commonly called e-cigarettes) may lead to combustible smoking initiation in adolescents.

Eligible Conditions
  • Positive Perceptions About Cigarette Smoking
  • Smoking Susceptibility
  • Attention Bias
  • Smoking Cues
  • Social Norms

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 30 minutes post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 30 minutes post intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
11-item scale that measures social normative beliefs about smoking
7-item explicit positive smoking expectancies scale
A 3-item scale that measures adolescent smoking susceptibility
+2 more
Secondary study objectives
13-item scale to Measure risk perception about e-cigarette use
13-item scale to measure risk perception about cigarette use
18-item scale that measures character attributes of actors that appeared in the commercials
+2 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: E-cigarette ad exposureActive Control1 Intervention
Participants in the e-cigarette ad exposure condition will view e-cigarette ads on the computer screen while having their eye movements tracked
Group II: non e-cigarette ad exposurePlacebo Group1 Intervention
Participants in the non e-cigarette ad exposure condition will view non e-cigarette ads on the computer screen while having their eye movements tracked

Find a Location

Who is running the clinical trial?

Dartmouth-Hitchcock Medical CenterLead Sponsor
536 Previous Clinical Trials
2,539,555 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,842 Previous Clinical Trials
41,002,868 Total Patients Enrolled
Dartmouth CollegeOTHER
86 Previous Clinical Trials
1,419,392 Total Patients Enrolled
~20 spots leftby Sep 2025